This site is intended for healthcare professionals

LABA/LAMA vs LABA/ICS in COPD patients at risk of exacerbation: the FLAME trial

Professor David Price presents the rationale, study design and key results from the FLAME trial, recently published in the New England Journal of Medicine, and provides his thoughts on the findings of the study from a primary care perspective.